$ISSC

Innovative Aerosystems (ISSC) Q3 2026 Earnings Call Transcript

Innovative Aerosystems (ISSC) reported Q3 FY2026 results in an earnings call. The company said revenue rose about 11% to $20.7 million, with net income of $4.5 million ($0.25 diluted share). Gross margin rose to nearly 52% and adjusted EBITDA grew about 75%. It also discussed the Aiden Displays acquisition, an eVTOL OEM contract, and a Nasdaq ticker change to IA on Aug. 18.

Original reporting
Published Aug 14, 2026, 2:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 2:51 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Innovative Aerosystems (ISSC) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ISSCBullishMed
01

Why it matters

Traders can focus on (1) the reported Q3 financial improvements, (2) the stated timing for engineering and production on the eVTOL program, (3) the acquisition’s strategic rationale, and (4) the Aug 18 Nasdaq ticker change plus small-cap index inclusion, which can create short-term trading and tracking effects.

02

Market read

The combination of Q3 margin expansion and multiple forward program milestones can shift expectations for defense and advanced air mobility avionics demand, while the Aug 18 ticker change and index inclusion can drive technical trading effects.

03

What to watch

The transcript mentions multiple program milestones (UMS2 production, L3 radio management unit, KC-767) but provides limited quantitative guidance for fiscal 26-27, making it harder to underwrite near-term revenue trajectory.

Relevance 7/10Novelty 6/10Timing: Aug 18 Nasdaq ticker change effective at US market open, plus Q3 earnings call details.

Background

Innovative Aerosystems (formerly ISSC) held a Q3 2026 earnings call, highlighting organic growth, margin expansion, an acquisition of Aiden Displays, and a new eVTOL OEM contract tied to its Liberty flight deck.

Company-level read

Ticker impact

$ISSCBullishMedium confidence
Context

Innovative Aerosystems reports Q3 results and progress on an acquisition and an OEM eVTOL contract, plus a planned Nasdaq ticker change.

Expected impact

Moderately positive bias, with potential volatility around the Aug 18 ticker change and any follow-on contract/production updates.

Evidence & confidence

The transcript discloses specific financial improvements (revenue, net income, gross margin, adjusted EBITDA) and concrete timing for engineering/production, which can re-rate expectations. However, it is an earnings call transcript rather than a fresh standalone filing, and the ticker-change mechanics may drive short-term technical effects more than fundamentals.

Market effects

Supports the defense and advanced air mobility avionics supply chain narrative via new OEM program development and display technology expansion.

Burdsboro, PA facility expansion and manufacturing transition could reinforce regional aerospace supplier employment and capex expectations.

Japanese eVTOL program development and 400+ order book references tie the story to cross-border advanced aviation demand.

Counterpoint

Large margin and EBITDA growth may be partly mix and timing-driven (e.g., prior-year F-16 pull-forward), so forward execution risk remains high for eVTOL production ramp.

Key entities

  • Innovative Aerosystems

    Reports Q3 2026 results, acquisition of Aiden Displays, and a new eVTOL OEM contract; announces Nasdaq ticker change to IA effective Aug 18.

  • Aiden Displays

    Rugged display technology developer acquired by Innovative Aerosystems, supporting 20+ military platforms and expanding into industrial applications.

  • L3

    Referenced for a radio management unit contract in final certification with production deliveries targeted for Q1 fiscal 27.

  • Boeing

    Referenced for KC-767 contract progressing per plan with production deliveries targeted for Q2 fiscal 27.

Related articles

$ISSCMed

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC): Results of Operations and Financial Condition

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2623046d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 INNOVATIVE AEROSYSTEMS REPORTS THIRD QUARTER FISCAL 2026 RESULTS Exton, PA, August 13, 2026 – Innovative Solutions & Support, Inc. (Nasdaq: ISSC) dba Innovative Aerosystems and its subsidiaries (“IA”) or the "Company", a

$ISSCLow

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC): Completion of Acquisition or Disposition of Assets

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-2.1 2 tm2620924d1_ex2-1.htm EXHIBIT 2.1 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. Exhibit 2.

$MDLNMed

Medline (MDLN) Q2 2026 Earnings Call Transcript

Medline (MDLN) Q2 2026 call said adjusted EBITDA rose 13% YoY to $1.1B, with higher costs partly offset by a $243M IEEPA tariff refund benefit. Q2 net sales grew 12% to $7.7B. Company raised fiscal 2026 organic sales outlook, but moderated adjusted EBITDA outlook citing Middle East conflict, Tracy warehouse fire, investments, quality remediation, and retail softness.

$KRTMedAI 8/10

Karat Packaging (KRT) Q2 2026 Earnings Call Transcript

Karat Packaging (KRT) reported Q2 2026 net sales of $136.3 million, up 9.9% year over year, and gross margin of 56.6% versus 39.6% a year ago. Results benefited from IEEPA tariff refunds, including 1,890 bps to gross margin. Net income rose 168.3% to $29.6 million. The company plans a new Orlando distribution center and guided Q3 sales growth in the low double digits.

$CRLMed

Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript

Charles River Laboratories (CRL) reported Q2 2026 results, citing a strengthening biopharmaceutical demand environment. DSA net book-to-bill rose to nearly 1.2x for a third straight quarter above 1x. Organic revenue growth returned to 0.1%. Operating margin improved 420 bps sequentially to 20.5% after divestitures. CRL also announced collaborations with Eli Lilly (TuneLab) and Arovella Therapeutics (NGS).

$BBNMed

Baby Bunting posts 33.9% rise in fiscal 2026 profit

Baby Bunting Group Ltd reported fiscal 2026 pro forma net profit of A$16.1m, up 33.9% from A$12.1m, on revenue of A$556.0m (+6.5%). Comparable sales rose 3.5%. Gross margin increased to 41.2%, and online sales were A$140.5m (25.3%). The company opened seven stores, reaching 80 outlets, and did not declare a final dividend.

Innovative Aerosystems (ISSC) Q3 2026 Earnings Call Transcript — alphai